Schizophrenia
27 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Mental Disorders
Narrower: Schizophrenia, Treatment-Resistant 1
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Aripiprazole for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Aripiprazole + IEM (Ingestible Event Marker) for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bupropion + Escitalopram + Venlafaxine + SERTRALINE for schizophrenia | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clozapine for schizophrenia | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Deep Brain Stimulation for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Diet-as-Usual (DAU) + LCHF Ketogenic Diet for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ecig 24 mg nicotine for schizophrenia | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Emraclidine for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for schizophrenia | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Evenamide 15 mg bid for schizophrenia, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| GXV-813 for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HS-10380 for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Iclepertin for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| KarX-EC + KarXT for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| KarXT for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic Diet for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic diet intervention for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ML-007C-MA for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Navigate for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NBI-1117570 for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Nmdae for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NMDAE plus AIFA for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Olz/sam for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Risperidone for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Ulotaront for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Xingqi Daozhi Decoction for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.